Back
Genmab AS 10K Form
Sell
50
GMAB
Genmab AS
Last Price:
$20.28
Seasonality Move:
7.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GMAB News And Ratings
See the #1 stock for the next 7 days that we like better than GMAB
GMAB Financial Statistics
Sales & Book Value
| Annual Sales: | $3B |
|---|---|
| Cash Flow: | $257M |
| Price / Cash Flow: | 11.96 |
| Annual Sales: | $8.36 |
| Price / Book: | 2.36 |
Profitability
| EPS (TTM): | 1.68190 |
|---|---|
| Net Income (TTM): | $1.1B |
| Gross Margin: | $2.9B |
| Return on Equity: | 22.23% |
| Return on Assets: | 18.18% |
Genmab AS Earnings Forecast
Key Genmab AS Financial Ratios
-
The Gross Profit Margin over the past 18 years for GMAB is 95.42%.
-
The Selling, General & Administrative Expenses for GMAB have been equal to 17.61% of Gross Profit Margin.
-
The Research & Development expenses have been 45.28% of Revenue.
-
The Interest Expense is 1.53% of Operating Income.
-
The Net Earning history of GMAB is 36.44% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 16 years.
Genmab AS Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GMAB |
| Website: | genmab.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.34 |
| Quick Ratio: | 5.32 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.92 |
|---|---|
| Forward P/E Ratio: | 10.99 |